Rapid infectious disease test GCT-110T

COVID-19pneumoniafor microbiology

This product is intended for the screening diagnosis of invasive fungal disease. It is used to provide rapid diagnostic reference for clinical invasive fungal infections through quantitative detection of (1-3)-β-D-glucan in the serum and Bronchoalveolar Lavage (BAL) fluid. Convenient Various specifications satisfy different requirements Easy Can be equipped with fully automatic instruments, easy and reduce errors Early 5-8 days prior to clinical symptoms and imaging Accurate Quality control ensures the experimental accuracy Recommended by the EORTC/MSG Consensus Group As one of the mycological criteria for the diagnosis of invasive fungal disease Linearity range 31.25-500 pg/mL Stability The reagent is stable for 3 years at 2-8°C in the dark